StockData
Amgen Inc logo

Amgen Inc

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$465.45−0.56 (-0.12%)

Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%

Amgen Research and Early Pipeline by Year

Research and Early Pipeline (Discovery through Phase 1) ($M) ($M)

Amgen Research and Early Pipeline: $1,732M in FY2025, up 12.9% from a year earlier. That is the highest of the 13 years on record here.

Latest, FY2025
1,732
Period ended Dec 31, 2025
Change on a year earlier
+12.9%
1,534 in FY2024
History
13 years
Since FY2013
Sources
11
Documents cited below

Where the FY2025 figure comes from

“|| Research and Early Pipeline | $ | 1,732 | $ | 1,534 | $ | 1,584”

Source: Form 10-K (amgn-20251231.htm, filed 2026-02-13) ↗

Reported in Form 10-K Item 7 MD&A R&D Expense by Category Table.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedResearch and Early Pipeline (Discovery through Phase 1) ($M) ($M)Year on yearSource
FY2025Dec 31, 20251,732+12.9%Form 10-K (amgn-20251231.htm, filed 2026-02-13) ↗
FY2024Dec 31, 20241,534-3.2%Form 10-K (amgn-20251231.htm, filed 2026-02-13) ↗
FY2023Dec 31, 20231,584-1.7%Form 10-K (amgn-20251231.htm, filed 2026-02-13) ↗
FY2022Dec 31, 20221,611-3.5%Form 10-K (amgn-20241231.htm, filed 2025-02-14) ↗
FY2021Dec 31, 20211,670+18.9%Form 10-K (amgn-20231231.htm, filed 2024-02-14) ↗
FY2020Dec 31, 20201,405-14.8%Form 10-K (amgn-20221231.htm, filed 2023-02-09) ↗
FY2019Dec 31, 20191,649+37.3%Form 10-K (amgn-20211231.htm, filed 2022-02-16) ↗
FY2018Dec 31, 20181,201+23.6%Form 10-K (amgn-20201231.htm, filed 2021-02-09) ↗
FY2017Dec 31, 2017972-6.4%Form 10-K (amgn-12312019x10kq42019.htm, filed 2020-02-12) ↗
FY2016Dec 31, 20161,039+4.2%Form 10-K (amgn-12312018x10kq42018.htm, filed 2019-02-13) ↗
FY2015Dec 31, 2015997-17.7%Form 10-K (amgn-12312017x10k.htm, filed 2018-02-13) ↗
FY2014Dec 31, 20141,212-1.7%Form 10-K (amgn-12312016x10k.htm, filed 2017-02-14) ↗
FY2013Dec 31, 20131,233–Form 10-K (amgn-12312015x10k.htm, filed 2016-02-16) ↗

Cite this data

StockData. (2026). Amgen Research and Early Pipeline ($M), annual FY2013–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/rd-cat-early

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.